149 related articles for article (PubMed ID: 38005867)
1. The Time-Dependent Association of Torque Teno Virus Load with the Level of SARS-CoV-2 S1 IgG Antibodies Following COVID-19 Vaccination in Kidney Transplant Recipients.
Imhof C; Messchendorp L; van Baarle D; Gansevoort RT; Van Leer-Buter C; Sanders JF
Viruses; 2023 Oct; 15(11):. PubMed ID: 38005867
[TBL] [Abstract][Full Text] [Related]
2. Prediction of humoral and cellular immune response to COVID-19 mRNA vaccination by TTV load in kidney transplant recipients and hemodialysis patients.
Graninger M; Stumpf J; Bond G; Görzer I; Springer DN; Kessel F; Kröger H; Frank K; Tonn T; Hugo C; Puchhammer-Stöckl E
J Clin Virol; 2023 May; 162():105428. PubMed ID: 36989730
[TBL] [Abstract][Full Text] [Related]
3. Torque teno virus viral load predicts SARS-CoV-2 vaccine response in kidney transplant recipients.
Solis M; Benotmane I; Gallais F; Caillard S; Fafi-Kremer S
J Med Virol; 2023 Jul; 95(7):e28936. PubMed ID: 37404001
[TBL] [Abstract][Full Text] [Related]
4. High torque tenovirus (TTV) load before first vaccine dose is associated with poor serological response to COVID-19 vaccination in lung transplant recipients.
Hoek RA; Verschuuren EA; de Vries RD; Vonk JM; van Baarle D; van der Heiden M; van Gemert JP; Gore EJ; Niesters HG; Erasmus M; Hellemons ME; Scherbeijn SM; Wijbenga N; Mahtab EAF; GeurtsvanKessel CH; Buter CVL
J Heart Lung Transplant; 2022 Jun; 41(6):765-772. PubMed ID: 35606065
[TBL] [Abstract][Full Text] [Related]
5. Torque teno virus DNA load as a predictive marker of antibody response to a three-dose regimen of COVID-19 mRNA-based vaccine in lung transplant recipients.
Gallais F; Renaud-Picard B; Solis M; Laugel E; Soulier E; Caillard S; Kessler R; Fafi-Kremer S
J Heart Lung Transplant; 2022 Oct; 41(10):1429-1439. PubMed ID: 35953352
[TBL] [Abstract][Full Text] [Related]
6. Torque teno virus (TTV): A gentle spy virus of immune status, predictive marker of seroconversion to COVID-19 vaccine in kidney and lung transplant recipients.
Roberto P; Cinti L; Napoli A; Paesani D; Riveros Cabral RJ; Maggi F; Garofalo M; Pretagostini R; Centofanti A; Carillo C; Venuta F; Gaeta A; Antonelli G
J Med Virol; 2023 Feb; 95(2):e28512. PubMed ID: 36661060
[TBL] [Abstract][Full Text] [Related]
7. Quantification of Torque Teno Virus Load to Monitor Short-term Changes in Immunosuppressive Therapy in Kidney Transplant Recipients.
Benning L; Reineke M; Bundschuh C; Klein JAF; Kühn T; Zeier M; Bartenschlager R; Schnitzler P; Morath C; Speer C
Transplantation; 2023 Dec; 107(12):e363-e369. PubMed ID: 37798825
[TBL] [Abstract][Full Text] [Related]
8. Smoking, Alcohol Intake and Torque Teno Virus in Stable Kidney Transplant Recipients.
Doorenbos CSE; Jonker J; Hao J; Gore EJ; Kremer D; Knobbe TJ; de Joode AAE; Sanders JSF; Thaunat O; Niesters HGM; Van Leer-Buter CC; Bakker SJL
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140628
[TBL] [Abstract][Full Text] [Related]
9. Torquetenovirus viral load is associated with anti-spike antibody response in SARS-CoV-2 mRNA BNT162b2 vaccinated kidney transplant patients.
Querido S; Adragão T; Pinto I; Ormonde C; Papoila AL; Pessanha MA; Gomes P; Ferreira S; Figueira JM; Cardoso C; Viana JF; Weigert A
Clin Transplant; 2022 Dec; 36(12):e14825. PubMed ID: 36301197
[TBL] [Abstract][Full Text] [Related]
10. High-Density Lipoprotein Particles and Torque Teno Virus in Stable Outpatient Kidney Transplant Recipients.
Jonker J; Doorenbos CSE; Kremer D; Gore EJ; Niesters HGM; van Leer-Buter C; Bourgeois P; Connelly MA; Dullaart RPF; Berger SP; Sanders JF; Bakker SJL
Viruses; 2024 Jan; 16(1):. PubMed ID: 38257843
[TBL] [Abstract][Full Text] [Related]
11. Prospective cohort study of Torque Teno Virus (TTV) viral load kinetics and the association with graft rejection in renal transplant patients.
Reyes NS; Laham G; Boccia N; García G; Jara R; Hermida E; Ricarte C; Diaz C; Soler Pujol G; Poletta FA; Echavarria M
J Clin Virol; 2023 Aug; 165():105501. PubMed ID: 37379781
[TBL] [Abstract][Full Text] [Related]
12. The kinetics of Torque Teno virus plasma load following calcineurin inhibitor dose change in kidney transplant recipients.
Regele F; Haupenthal F; Doberer K; Görzer I; Kapps S; Strassl R; Bond G
J Med Virol; 2024 Mar; 96(3):e29554. PubMed ID: 38511586
[TBL] [Abstract][Full Text] [Related]
13. Systemic oxidative stress may be associated with reduced IgG antibody titers against SARS-CoV-2 in vaccinated kidney transplant recipients: A post-hoc analysis of the RECOVAC-IR observational study.
van Eijk LE; Bourgonje AR; Messchendorp AL; Bulthuis MLC; Reinders-Luinge M; Doornbos-van der Meer B; Westra J; den Dunnen WFA; Hillebrands JL; Sanders JF; van Goor H;
Free Radic Biol Med; 2024 Mar; 215():14-24. PubMed ID: 38395091
[TBL] [Abstract][Full Text] [Related]
14. The role of interleukin-21 in COVID-19 vaccine-induced B cell-mediated immune responses in patients with kidney disease and kidney transplant recipients.
Malahe SRK; Hartog YD; Rietdijk WJR; van Baarle D; de Kuiper R; Reijerkerk D; Ras AM; Geers D; Diavatopoulos DA; Messchendorp AL; van der Molen RG; Remmerswaal EBM; Bemelman FJ; Gansevoort RT; Hilbrands LB; Sanders JS; GeurtsvanKessel CH; Kho MML; de Vries RD; Reinders MEJ; Baan CC;
Am J Transplant; 2023 Sep; 23(9):1411-1424. PubMed ID: 37270109
[TBL] [Abstract][Full Text] [Related]
15. TTV viral load as a predictor of antibody response to SARS COV-2 vaccination.
Focosi D; Baj A; Azzi L; Novazzi F; Maggi F
J Heart Lung Transplant; 2023 Feb; 42(2):143-144. PubMed ID: 36424253
[TBL] [Abstract][Full Text] [Related]
16. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
Reindl-Schwaighofer R; Heinzel A; Mayrdorfer M; Jabbour R; Hofbauer TM; Merrelaar A; Eder M; Regele F; Doberer K; Spechtl P; Aschauer C; Koblischke M; Paschen C; Eskandary F; Hu K; Öhler B; Bhandal A; Kleibenböck S; Jagoditsch RI; Reiskopf B; Heger F; Bond G; Böhmig GA; Strassl R; Weseslindtner L; Indra A; Aberle JH; Binder M; Oberbauer R
JAMA Intern Med; 2022 Feb; 182(2):165-171. PubMed ID: 34928302
[TBL] [Abstract][Full Text] [Related]
17. The association of Torque Teno viral load with CMV and BKV infection in pediatric and adolescent kidney transplant patients.
Eibensteiner F; Messner I; Uhl P; Bond G; Puchhammer-Stoeckl E; Mueller-Sacherer T; Aufricht C; Rusai K
J Clin Virol; 2024 Jun; 172():105673. PubMed ID: 38564881
[TBL] [Abstract][Full Text] [Related]
18. Development of a standardized real time PCR for Torque teno viruses (TTV) viral load detection and quantification: A new tool for immune monitoring.
Kulifaj D; Durgueil-Lariviere B; Meynier F; Munteanu E; Pichon N; Dubé M; Joannes M; Essig M; Hantz S; Barranger C; Alain S
J Clin Virol; 2018 Aug; 105():118-127. PubMed ID: 29957546
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of one and two booster doses of SARS-CoV-2 mRNA vaccines in kidney transplant recipients: A randomized clinical trial.
Drenko P; Kacer M; Kielberger L; Vlas T; Topolcan O; Kucera R; Reischig T
Transpl Infect Dis; 2023 Oct; 25(5):e14150. PubMed ID: 37724748
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of Torque Teno virus DNAemia in critically ill COVID-19 patients: May it help to predict clinical outcomes?
Forqué L; Albert E; Giménez E; Torres I; Carbonell N; Ferreres J; Blasco ML; Navarro D
J Clin Virol; 2022 Mar; 148():105082. PubMed ID: 35091226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
